Cancer ‘survivor-care’: II. Disruption of prefrontal brain activation top-down control of working memory capacity as possible mechanism for chemo-fog/brain (chemotherapy-associated...

Por Raffa, Robert B.
Publicado em 2013

Identification of an additional supraspinal component to the analgesic mechanism of action of buprenorphine

Por Ding, Zhe, Raffa, Robert B
Publicado em 2009

The pain chronicles: Cures, myths, mysteries, prayers, diaries, brain scans, healing, and the science of suffering

Por Raffa, Robert B., Porreca, Frank
Publicado em 2011

Chemo fog cancer chemotherapy-related cognitive impairment /

Por Raffa, Robert B., Tallarida, Ronald J.
Publicado em 2010

Modified ‘Joyce model’ of opioid dependence/withdrawal

Por Raffa, Robert B., Tallarida, Ronald J.
Publicado em 2006

Potential insight for drug discovery from high fidelity receptor-mediated transduction mechanisms in insects

Por Raffa, Robert B., Raffa, Kenneth F.
Publicado em 2011

Intracerebroventricular opioids for intractable pain

Por Raffa, Robert B, Pergolizzi, Joseph V
Publicado em 2012

The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinations

Por Tallarida, Ronald J., Raffa, Robert B.
Publicado em 2010

Flumazenil-sensitive dose-related physical dependence in planarians produced by two benzodiazepine and one non-benzodiazepine benzodiazepine receptor agonists

Por Raffa, Robert B., Cavallo, Federica, Capasso, Anna
Publicado em 2007

Controlled release formulation of oxycodone in patients with moderate to severe chronic osteoarthritis: a critical review of the literature

Por Taylor, Robert, Raffa, Robert B, Pergolizzi, Joseph V
Publicado em 2012

In vivo comparison of harmine efficacy against psychostimulants: preferential inhibition of the cocaine response through a glutamatergic mechanism

Por Owaisat, Suzan, Raffa, Robert B., Rawls, Scott M.
Publicado em 2012

Cocaine synergism with alpha agonists in rat aorta: computational analysis reveals an action beyond reuptake inhibition

Por Lamarre, Neil S., Raffa, Robert B., Tallarida, Ronald J.
Publicado em 2012

Naltrexone extended-release injection: an option for the management of opioid abuse

Por Taylor, Robert, Raffa, Robert B, Pergolizzi, Joseph V
Publicado em 2011

On deriving the dose–effect relation of an unknown second component: An example using buprenorphine preclinical data

Por Tallarida, Ronald J., Cowan, Alan, Raffa, Robert B.
Publicado em 2010

‘Null Method’ Determination of Drug Biophase Concentration

Por Tallarida, Ronald J., Lamarre, Neil, Raffa, Robert B.
Publicado em 2011

Opioid formulations with sequestered naltrexone: a perspective review

Por Taylor, Robert, Raffa, Robert B., Pergolizzi, Joseph V.
Publicado em 2014

The Potential Role of an Extended-Release, Abuse-Deterrent Oxycodone/Acetaminophen Fixed-Dose Combination Product for the Treatment of Acute Pain

Por Pergolizzi, Joseph V., Taylor, Robert, Raffa, Robert B.
Publicado no Adv Ther (2015)

Principles in general pharmacology

Por Tallarida, Ronald J., Raffa, Robert B., McGonigle, Paul.
Publicado em 1988

Nonlinear isobologram and superadditive withdrawal from cocaine:cannabinoid combinations in planarians

Por Raffa, Robert B., Stagliano, Gregory W., Tallarida, Ronald J.
Publicado em 2006

Analgesic combinations

Por Raffa, Robert B., Pergolizzi, Joseph V., Tallarida, Ronald J.
Publicado em 2010